Skip to main content

Table 1 Nutritional composition of trial supplements – amounts per day a

From: Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial

Nutrient

First phase supplement (from recruitment to 2 weeks of ART)

Second phase supplement (from 2 to 6 weeks of ART)

LNS-VM (30 g)

LNS (30 g)

LNS-VM (250 g)

LNS (250 g)

Calories (kcal)

139

168

1,397

1,416

Protein (g)

2.4

2.3

55

55

Fat (g)

11.0

10.9

97.5

97.5

Potassium (mmol)

30

0.9

32

15.8

Phosphorus (mmol)

47

0.4

38

9.3

Magnesium (mmol)

16

0.3

17

5.7

Calcium (mg)

29.8

5.0

140

115

Iron (mg)

0.4

0.4

14.7

8.4

Zinc (mg)

21

0.2

21

3.8

Copper (mg)

3.6

0.06

3.6

1.2

Manganese (mg)

4.2

–

4.2

–

Iodine (μg)

420

–

420

–

Selenium (μg)

180

–

180

–

Chromium (μg)

75

–

75

–

Retinol (as palmitate) (μg)

1,800

–

1,800

–

Vitamin D (μg)

10

–

10

–

Vitamin E (mg)

45

–

45

–

Vitamin K (μg)

95

–

95

–

Vitamin C (mg)

120

–

120

–

Thiamin (mg)

2.4

–

2.4

–

Riboflavin (mg)

3.3

–

3.3

–

Niacin (mg)

39

–

39

–

Pyridoxine (mg)

3.6

–

3.6

–

Folate (μg)

600

–

600

–

Vitamin B12 (μg)

4.5

–

4.5

–

Pantothenic acid (mg)

9

–

9

–

  1. aWhere nutrient contents are provided for both LNS and LNS-VM, these are values from analysis by the manufacturer, accounting for inter-batch variability; where values for only LNS-VM are given, these where not assessed in the prepared foods but refer to amounts added, that is, they do not include those intrinsic to the LNS.
  2. ART, Antiretroviral therapy; LNS, Lipid-based nutritional supplement; LNS-VM, LNS with added vitamins and minerals.